Conclusion
Our study sheds light on the possible mechanisms through which
thalidomide and lenalidomide might be effective in the management of
SARS-coV-2 pathology. Thalidomide and derivatives effectively modulating
various aberrantly regulated pathways infections with abundant
pharmacological information available make them promising candidates for
the treatment of novel coronavirus infections.